Velcade in MALT Lymphoma Patients

NCT00373906 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

MALT Lymphoma

Interventions

DRUG: Bortezomib (Velcade)

Sponsor

Medical University of Vienna